| Financial Year |
March 31 2023 |
| Monetary Funds |
402,908,082.22 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
27,355,430.05 |
| Advances to Suppliers |
9,811,367.92 |
| Other Receivables |
6,493,697.77 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
221,118,840.17 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,600,657.87 |
| Total Current Assets |
680,288,076.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
218,048,026.48 |
| Investment Properties |
-- |
| Fixed Assetes |
461,586,815.46 |
| Under-construction Projects |
38,592,473.48 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
24,287,689.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
582,846.69 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
11,880,000.00 |
| Sub-Total of Non-Current Assets |
756,591,018.14 |
| Total Assets |
1,436,879,094.14 |
| Short-Term Loans |
74,530,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
47,488,940.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
33,617,216.62 |
| Taxes Payable |
10,575,531.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
237,776,468.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
477,601.80 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
418,787,523.92 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,000,400.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
75,175,249.46 |
| Total Liabilities |
493,962,773.38 |
| Paid-In Capital(Or Share Stock) |
365,858,712.00 |
| Capital Surplus |
783,917,419.42 |
| Surplus Reserve |
82,726,748.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-292,939,749.44 |
| Minority Stockholder's Interest |
37,742,225.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
905,174,095.31 |
| Owner's Equity（Stockholder's Equity） |
942,916,320.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,436,879,094.14 |
